International Clinical Trial: Skin Safety test of AC Horizon Sunscreen

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119248) titled 'Skin Safety test of AC Horizon Sunscreen' on Oct. 9.

Study Type: Interventional

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: AC Horizon Ventures LLP

Intervention: Intervention1: Finn chamber: Each patch contains 0.04gm (40 microliter), of 1. Sunscreen, 2.Negative control(0.9 Percent NaCl), 3.Positive Control- (1 Percent SLS) Route of Administration: Topical Frequency: Once Duration:48 hrs Control Intervention1: Not Applicable: Not Applicable

Recruitment Status...